A novel multipotent sigma 1/M1 muscarinic activator for a comprehensive therapeutic strategy in Alzheimer’s disease

Anavex-1-1666x833.png

International Geneva/Springfield Symposium on Advances in Alzheimer Therapy (2014), Geneva, Switzerland

A. Fisher, R. Medeiros, N. Bar-Ner, N. Natan, R. Brandeis, H. Elkon, V. Nahum, G. Grigoryan, M. Segal and F. Laferla


View Poster

1/0